Aurobindo Pharma Unit Acquires Ace Laboratories For Rs 18 Crore
The company was acquired for nearly Rs 18 crore on a debt-free basis.28-06-2024
28-06-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation of acquisition of entire share capital of Ace Laboratories Limited, UK by Agile Pharma B.V., The Netherlands, a wholly owned step-down subsidiary of the Company for a consideration of INR 17.91 Crore on debt free basis.28-06-2024
AUROBINDO PHARMA LTD. - 524804 - Classification Of US FDA Inspection At The Injectable Facility Of Eugia SEZ Pvt. Ltd.
Intimation of classification of US FDA inspection at the injectable facility of Eugia SEZ Pvt. Ltd., a wholly owned step- down subsidiary of the Company.27-06-2024
AUROBINDO PHARMA LTD. - 524804 - Closure of Trading Window
Intimation of closure of trading window for dealing in shares of the Company in connection with the declaration of unaudited financial results for the quarter ending on June 30, 2024.26-06-2024
AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of letters of credit in lieu of lost share certificates.14-06-2024
AUROBINDO PHARMA LTD. - 524804 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kirthi Reddy Kambam12-06-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investors meet scheduled on June 13, 2024.10-06-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet scheduled on June 11, 2024.06-06-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet scheduled on June 10, 2024.06-06-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet scheduled on 18.06.2024.06-06-2024